Back to top

Dermata says Australian Patent Office accepts Spongilla tech application

Dermata Therapeutics (DRMA) announced the Australian Patent Office has accepted Dermata’s patent application for its Spongilla technology combinati...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Dermata Therapeutics, Inc. (DRMA)